Efficacy and safety of preoperative chemotherapy in real world patients with locally advanced gastric/gastroesophageal junction adenocarcinoma

Corresponding author: quyanli, qumedical@163.com

DOI: 10.12201/bmr.202409.00052

•  

  Abstract: Objective: To retrospectively analyze the efficacy and safety of preoperative chemotherapy of two or three drugs in patients with locally advanced gastric/gastroesophageal adenocarcinoma in the real world. Methods: Retrospective collection of cT3-4N+M0 gastric/gastroesophageal adenocarcinoma admitted to the Affiliated Cancer Hospital of Xinjiang Medical University between January 2016 and December 2021 and underwent surgery after neoadjuvant chemotherapy. According to the exclusion criteria, a total of 112 cases were collected, including 36 cases in the two drug group, 76 cases in the three-drug group. All patients underwent preoperative chemotherapy and postoperative adjuvant treatment. Results: There is no significant difference between the two-drug/three-drug regimen for the patients OS, DFS, R0 rate, tumor downgrade(P>0.05); the patients age, surgical method, tumor downgrade, postoperative pathological staging, and pathological differentiation type are the independent risk factors affecting the patients OS and DFS (P<0.05). Conclusion: The preoperative chemotherapy regimen of two or three drugs has no significant impact on the prognosis of the patient, the decline of the tumor, and the resection of R0/R1, but the patients age, postoperative pathological staging, the downgrade of the tumor, and the pathological differentiation type have a certain impact on the prognosis of the patient.

  Key words: Locally; advanced gastric; cancer? Preoperative; chemotherapy? Tumor; downgrade

  Submit time: 23 September 2024

  Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
• html

• 图表

• YaQin Hao, YunFeng Hu, Jing Hao, Xin Zhao. Research of circular RNA and autophagy in gastric cancer. 2023. doi: 10.12201/bmr.202304.00001

  Wuhuan, Luoyushuang. Circulating Tumor Cell HER-2 Expression in the Targeted Therapy of Gastric Adenocarcinoma. 2024. doi: 10.12201/bmr.202408.00001

  Wang Yaoqiang, Wang Haohao, Luo Changjiang. The role of HMGB1 in the progression and therapy of Gastric Cancer. 2024. doi: 10.12201/bmr.202412.00009

  ZhouMengqian, Tang Tong. Prediction of Lateral Cervical Lymph Node metastasis risk in Thyroid Cancer based on preoperative Lymph Node Ultrasonographic Characteristics. 2024. doi: 10.12201/bmr.202410.00035

  Zhang Aiqin. Zhang Aiqins Experience in Treating Ovarian Cancer after Operation and Chemotherapy. 2024. doi: 10.12201/bmr.202411.00016

  Zhao Qun. Young Chemotherapy Resistant Choriocarcinoma：Case Report and Literature Review. 2024. doi: 10.12201/bmr.202411.00007

  LIU Chaoyi, Hong Yuan, ZENG Jiahui. Application of AIGC Whole Process Message Push Platform In Operating Room of Cancer Hospital. 2024. doi: 10.12201/bmr.202412.00036

  liuyaru, shihao, sunguanqun, dongjingjing, yehanfeng, zhengleyi, sundan. Design and Research of Intelligent Remote Management System for Tumor Patients after Immunotherapy. 2022. doi: 10.12201/bmr.202206.00007

  刘永淳, Luo Liangtao, Gao Zhongying. Professor Gao Zhongyings experience in treating chronic atrophic gastritis from the theory of. 2024. doi: 10.12201/bmr.202410.00062

  fengqi, songcaiyuan, lilunxin. Efficacy and safety of Zhangs Qingre Xiaoyu Decoction combined with VSD in the treatment of open tibia and fibula fracture wound infection. 2024. doi: 10.12201/bmr.202410.00023

• ID	Submit time	Number	Download
  1	2024-07-01	bmr.202409.00052V1	Download

• Public  Anonymous  To author only Submit Comments